Researchers at Emory University have linked a daily vitamin D supplement intake of 5,000 international units or more to a 13 percent higher score on cognitive tests among older adults experiencing sleep disturbances and mild cognitive impairment, according to a study published in Sleep Medicine.
A common, inexpensive daily vitamin is gaining fresh attention from researchers tracking the early stages of cognitive decline. Scientists at Emory University found that older adults dealing with both sleep disturbances and mild cognitive impairment who took a daily dose of at least 5,000 international units of vitamin D scored significantly higher on standard cognitive evaluations than their peers who did not use the supplement.
The findings, reported in Sleep Medicine, center on a group of 54 adults aged 50 or older. All participants presented with diagnosed or suspected mild cognitive impairment alongside sleep complaints. As Alzheimer’s disease rates climb globally, researchers are hunting for accessible, modifiable factors that might protect brain health before neurodegeneration hardens into permanent cognitive loss.
Cognitive Test Scores and the 5,000 IU Threshold at Emory University
During the study, researchers evaluated participants using the Montreal Cognitive Assessment, a screening tool designed to measure memory, attention, and executive function. Participants also completed the Pittsburgh Sleep Quality Index and the Epworth Sleepiness Scale to quantify their sleep disturbances.
When the Emory team cross-referenced daily vitamin D intake against these cognitive and sleep metrics—adjusting for age, sex, body mass index, education level, and the specific type of vitamin D used—a clear pattern emerged. Participants taking 5,000 IU or more daily scored roughly 13 percent higher on the Montreal Cognitive Assessment than non-users, amounting to a 3.78-point difference.
This may represent a critical window for intervention, when cognitive changes are emerging, but opportunities to support brain health may remain,
Victoria Pak, Emory University
Victoria Pak, associate professor at Emory University’s Nell Hodgson Woodruff School of Nursing and senior author of the study, emphasized that the timing of such an intervention could prove pivotal. Mild cognitive impairment occupies the gray zone between normal age-related cognitive shifts and full clinical dementia.
Comparing Vitamin D Forms and Examining Sleep Disturbance Links
The research team also investigated whether the chemical form of the supplement altered its association with cognitive performance.
The study was funded by the National Institute on Aging of the National Institutes of Health under grants R01AG097853-01 and R61AG080606. Alongside Pak, the Emory research team included co-authors Sirui Zhou, Paul Sudeshna, Lynn Marie Trotti, and Donald Bliwise.
Researchers stress that the 5,000 IU threshold sits slightly above the generally accepted safe upper limit of 4,000 IU per day established to prevent hypercalcemia, meaning the findings do not constitute an immediate dosing recommendation. Instead, the study provides a preliminary foundation for larger clinical trials to determine whether targeted supplementation can actively slow cognitive decline in high-risk populations.
Broader Lifestyle Factors and Vascular Risks in Dementia Progression
Parallel research emphasizes that vitamin intake operates within a much wider web of modifiable health risks that influence long-term brain health. A prospective cohort study published in The Journal of Prevention of Alzheimer’s Disease by researchers at Sweden’s Lund University tracked nearly 500 participants over four years to examine how lifestyle factors accelerate different forms of brain damage.
The Lund team monitored white matter hyperintensities—nerve fiber alterations tied to vascular dementia—alongside amyloid-beta and tau proteins associated with Alzheimer’s disease. They found that vascular and metabolic risks, including high blood pressure, smoking, and elevated blood lipids, strongly correlate with accelerated white matter damage. Diabetes was specifically linked to faster amyloid-beta buildup, while a lower body mass index tracked with quicker tau accumulation.
Focusing on vascular and metabolic risk factors can still help reduce the combined effects of several brain changes that occur simultaneously,
Sebastian Palmqvist, Lund University
Sebastian Palmqvist, study author and senior lecturer in neurology at Lund University, noted that prior scientific literature often overlooked the distinct underlying pathologies driving different types of dementia. By addressing modifiable cardiovascular and nutritional targets concurrently—ranging from blood pressure management and physical activity to accessible interventions like vitamin D supplementation—clinicians hope to build a more robust defense against the rising tide of cognitive disorders.
По теме
